Michelle Tianqing Liu

LINKEDIN (opens in a new window) | TWITTER (opens in a new window)

PhD, BPharm, MRSC
Vice-Chancellor's Research Fellow - Pharmacologist/Natural Products Chemistry, NICM Health Research Institute

Dr Tianqing (Michelle) Liu joined NICM Health Research Institute in 2020 as Western Sydney University Vice-Chancellor’s Research Fellow, working in the area of pharmacology and natural product chemistry. She has an interest in human cancers and neurological disorders, with her current research focus on the use of nanotechnology to overcome medical barriers in disease diagnosis and therapy.

Dr Liu has been recognised for scientific excellence with several grants, fellowships and awards including 2015 Women in Technology Rising Star Award and as 2019 finalist for L'Oréal-UNESCO For Women in Science Australian & New Zealand Fellowship for her work in developing nanomedicines for disease diagnosis and treatment. Her research is highly productive, and has lead to 35 original research publications in leading journals such as ACS NANO (IF 13.9), Nano Letters (IF 12.7), Biomaterials (IF 10.3), Nanoscale, ACS Applied Materials & Interfaces. She has given 25 presentations at national/international conferences, 8 of which were as invited speakers.

Research focus

  • Design and synthesis of advanced biomaterials for disease prevention, diagnosis and therapy.
  • Mechanisms of iron-related cell death in diseased conditions.
  • Role of immune cells exosomes in cancer and neurological disorders.

Awards and recognitions

  • 2020 Vice-Chancellor’s Research Fellowship, Western Sydney University
  • 2020 Journal C Best Paper Award, Journal of Carbon Research
  • 2019 Finalist of L'Oréal-UNESCO For Women in Science Australian & New Zealand Fellowship
  • 2019 Finalist of ASMR Queensland Health & Medical Research Awards (Early Career)
  • 2018 The Bridge Program Best Team Pitch Presentation (selected by Pfizer and Novartis)
  • 2018 The Bridge Program Travel Award
  • 2016 NHMRC Peter Doherty - Australian Biomedical Fellowship
  • 2015 Women in Technology Rising Star Award
  • 2014 Chinese Academy of Science Visiting Fellowship for Overseas
  • 2013 Chinese Government Award for Outstanding Students Studying Abroad


  • Member, Controlled Release Society (CRS)
  • Member, Royal Society of Chemistry (RSC)
  • Member, Australian Nanotechnology Network (ANN)
  • Member, Australasian Pharmaceutical Science Association
  • Member, Australian Society for Medical Research
  • Member, Gastroenterological Society of Australia
  • Member, Australia Chinese Association for Biomedical Science
  • Member, Australian Synchrotron
  • Member, Women in Technology (WiT)
  • 2020 Reviewer, Molecular pharmaceutics
  • 2019-present Member, Australia-China Pharmaceutical Innovation Network (ACPIN)
  • 2019-present Reviewer, ACS Applied Materials and Interfaces
  • 2019-present Reviewer, ACS Sensors
  • 2019-present Reviewer, International Journal of Nanomedicines
  • 2019-present Reviewer, Theranostics
  • 2018-present Reviewer, Analyst
  • 2018-present Reviewer, Cellular Signalling
  • 2018-present Reviewer, Evidence-Based Complementary and Alternative Medicine
  • 2016-present Reviewer, Toxicology Letters
  • 2016-2018 Member, Australian Society for Medical Research (ASMR)
  • 2015-present Reviewer, RSC Advances


  • 2014 PhD (Nanomedicine and Bionanomaterials), University of South Australia, Australia
  • 2007 Bachelor of Pharmacy (Advance Program), Wuhan University, China


For a full listing of publications please see: